Methimazole hepatitis [1];Hepatitis por metimazol

Revista Clinica Espanola

Volumn 204, Issue 7, 2004, Pages 388-

  Pinero Madrona A ^a   Pons Minano J A ^a   Madrid Conesa, J ^a   Parrilla Paricio, P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; IMIDAZOLE; LIVER ENZYME; THIAMAZOLE; TIRODRIL;

ADULT; ASPIRATION BIOPSY; CASE REPORT; DRUG INDICATION; FEMALE; HEPATITIS; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; LABORATORY TEST; LETTER; SYMPTOMATOLOGY;

EID: 4043151376     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13063535     Document Type: Letter

References (6)

1. Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Saf 1996;15:53-63.
2. Kim HJ, Kim BH, Han YS, Yang I, Kim KJ, Dong SH, et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single center retrospective study. Am J Gastroenterol 2001;96:165-9.
3. Sadoul JL, Carrivet B, Freychet P. Toxic hepatitis induced by antithyroid drugs: four cases including one with cross reactivity between carbimazole and benzylthiouracil. Eur J Med 1993;2:473-7.
4. Schwab GP, Wetscher GJ, Vogl W, Redmond E. Methimazol-induced cholestatic liver injury mimicking sclerosing cholangitis. Langenbecks Arch Chir 1996;381:225-7.
5. Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propilthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997;82:1727-33.
6. Epeirier JM, Pageaux GP, Coste V, Perigault PF, Bauc P, Larrey D, et al. Fulminant hepatitis after carbimazole and propranolol administration. Eur J Gastroenterol Hepatol 1996:8:287-8.